Form 4 for ELTX Elicio Therapeutics, Inc.
Accepted 2021-12-17 00:00:00 ET · period of report 2021-06-24 · accession 0001601485-21-000087 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2021-12-17 | 2021-12-15 | ELTX | Venkatesan Jay | See Remarks, Dir | P - Purchase | $2.41 | +77.6K | 1.32M | +6% | +$187.0K | |
| 2021-12-17 | 2021-06-24 | ELTX | Venkatesan Jay | See Remarks, Dir | F - Tax | $13.78 | -41.1K | 1.24M | -3% | -$566.2K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2021-12-15 | P | A | 77,604 | $2.41 | 1,316,861 | D | — | — | |
| 2 | Common | Common Stock | 2021-06-24 | F | D | 41,091 | $13.78 | 1,239,257 | D | — | — |